JPMorgan Chase & Co’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$291K Buy
25,655
+5,398
+27% +$61.3K ﹤0.01% 4298
2025
Q1
$135K Buy
20,257
+293
+1% +$1.95K ﹤0.01% 4601
2024
Q4
$220K Buy
19,964
+4,512
+29% +$49.8K ﹤0.01% 4492
2024
Q3
$190K Buy
15,452
+199
+1% +$2.45K ﹤0.01% 4475
2024
Q2
$206K Buy
15,253
+4,309
+39% +$58.2K ﹤0.01% 4265
2024
Q1
$148K Sell
10,944
-7,189
-40% -$97.1K ﹤0.01% 4580
2023
Q4
$95.4K Sell
18,133
-8,397
-32% -$44.2K ﹤0.01% 4787
2023
Q3
$105K Buy
26,530
+3,363
+15% +$13.3K ﹤0.01% 4579
2023
Q2
$246K Sell
23,167
-91,300
-80% -$971K ﹤0.01% 4170
2023
Q1
$954K Buy
114,467
+90,608
+380% +$755K ﹤0.01% 3474
2022
Q4
$220K Buy
23,859
+291
+1% +$2.68K ﹤0.01% 4166
2022
Q3
$302K Buy
23,568
+1,070
+5% +$13.7K ﹤0.01% 3990
2022
Q2
$297K Buy
22,498
+2,890
+15% +$38.2K ﹤0.01% 4143
2022
Q1
$412K Buy
19,608
+3,374
+21% +$70.9K ﹤0.01% 4114
2021
Q4
$390K Buy
16,234
+1,506
+10% +$36.2K ﹤0.01% 4206
2021
Q3
$375K Buy
14,728
+983
+7% +$25K ﹤0.01% 4106
2021
Q2
$463K Buy
13,745
+4,156
+43% +$140K ﹤0.01% 4045
2021
Q1
$373K Buy
9,589
+3,573
+59% +$139K ﹤0.01% 4194
2020
Q4
$373K Buy
6,016
+1,462
+32% +$90.6K ﹤0.01% 3908
2020
Q3
$156K Sell
4,554
-137
-3% -$4.69K ﹤0.01% 3848
2020
Q2
$112K Sell
4,691
-814
-15% -$19.4K ﹤0.01% 3917
2020
Q1
$126K Buy
5,505
+2,486
+82% +$56.9K ﹤0.01% 3877
2019
Q4
$86K Buy
3,019
+18
+0.6% +$513 ﹤0.01% 4080
2019
Q3
$64K Buy
+3,001
New +$64K ﹤0.01% 4149